This article was originally published by S.D. Wells at Natural News.
Plandemic “officials” in the USA would love to install a new fear-based media frenzy to get everybody mass-injected with more spike prions that cause turbo cancer, infertility, blood clots and early death. The latest chikungunya dengue outbreak is perfect cannon fodder, so they’re jumping right on it. It’s chum in the water.
Health officials in the United States are raising concerns after new cases of chikungunya, a mosquito-borne virus currently sweeping through China, were reported among American travelers. The Centers for Disease Control and Prevention (CDC) confirmed four additional cases this week, bringing the US total to 50 so far this year. All of these infections were contracted abroad, primarily in Asia and South America, though it remains unclear how many are tied directly to China’s surging outbreak.
-
- Chikungunya surge in China and U.S. cases: China is experiencing its largest-ever outbreak with more than 10,000 cases, while the U.S. has reported 50 imported cases so far this year, all linked to travel in affected regions such as Asia and South America.
-
- CDC issues travel warnings: The CDC has issued a Level 2 travel advisory for China and several other countries, urging Americans to take precautions against mosquito bites. Cruise lines and state health departments have also issued alerts.
-
- Transmission risks in the U.S.: Although the U.S. hasn’t seen local transmission since 2019, experts warn infected travelers could enable Aedes mosquitoes to spread the virus domestically, given high travel volumes between China and the U.S.
-
- Symptoms and prevention: Chikungunya causes sudden high fever, severe joint pain, rash, and fatigue, with risks of long-term complications. There is no cure, but vaccines exist for travelers, and prevention focuses on avoiding mosquito bites.
U.S. records more cases of virus, prompting COVID-era restrictions in China as travel warnings take effect
Chikungunya, transmitted by the Aedes mosquito—the same species that spreads dengue, Zika, and yellow fever—causes sudden high fever and severe joint pain that can leave sufferers debilitated for months. Other symptoms include headache, rash, muscle aches, and swelling of the eyes. While most cases resolve within 7–10 days, complications involving the heart and brain can develop in severe infections, and some patients experience lifelong joint problems. The CDC estimates that 15–35 percent of infected individuals show no symptoms, making detection and containment challenging.
China is currently grappling with its largest recorded outbreak of chikungunya, with more than 10,000 cases logged this year. Authorities have deployed drones to spray insecticides in mosquito-prone areas to slow the spread, but more than 1,000 new cases were still reported last week alone. The outbreak has triggered Covid-era style restrictions and travel advisories, with the CDC issuing a Level 2 alert urging Americans to take extra precautions when visiting China. The advisory also extends to countries including Brazil, Colombia, India, Mexico, Nigeria, Pakistan, the Philippines, and Thailand, where chikungunya remains endemic.
The US has not reported local transmission of the virus since 2019, but experts warn the risk is increasing due to global travel. With roughly 1.6 million people traveling between the US and China annually, an infected traveler could be bitten by a local mosquito, allowing the virus to establish transmission chains in American communities. “This outbreak in China is very concerning,” said Dr. Louisa Messenger, a mosquito researcher in Nevada. “It could already be here in the US; and really, it’s just one plane flight away.”
The CDC has classified chikungunya as a nationally notifiable disease, meaning health departments can voluntarily report cases for federal monitoring. Historically, the US recorded around 30 imported cases annually between 2006 and 2013, but the number spiked dramatically in 2014 with nearly 2,800 cases, including 12 locally acquired in states and territories such as Florida, Texas, Puerto Rico, and the US Virgin Islands.
Travel agencies and cruise lines are now echoing CDC warnings. Norwegian Cruise Line recently advised passengers to use insect repellent and wear permethrin-treated clothing after Italy reported its first local cases of both chikungunya and dengue. Similarly, health officials in New Jersey and Massachusetts have urged residents to avoid outbreak areas and take preventive measures against mosquito bites.
There is currently no specific cure for chikungunya. Treatment focuses on symptom relief using pain relievers and fever reducers, though two vaccines are available for travelers heading to outbreak regions. Pregnant women face additional risks, as the virus can be transmitted to newborns during childbirth, potentially leading to severe illness.
With chikungunya’s resurgence abroad and rising imported cases at home, US health officials stress vigilance. The growing global spread highlights the need for heightened travel precautions, robust mosquito control measures, and public awareness to prevent another major outbreak on American soil.
Bookmark Infections.news to get the latest updates on chikungunya virus and Bill Gates syndrome sweeping the world under the depopulation scheme that’s underway.
Read the full article here
